Back to JACOBS LEVY EQUITY MANAGEMENT, INC JACOBS LEVY EQUITY MANAGEMENT, INC

NVCRNVCR
Showing 5 of 20 quarters

Position history for JACOBS LEVY EQUITY MANAGEMENT, INCJACOBS LEVY EQUITY MANAGEMENT, INC's holdings in NOVOCURE LTD

Yes. Jacobs Levy Equity Management holds 1,164,072 shares of NVCR (Novocure), worth $17.6M, as of its Q2 2026 13F filing. It reduced the position by 167,420 shares (-12.6%) from Q1 2026. Jacobs Levy Equity Management has held NVCR since Q2 2025, across 5 quarterly 13F filings. NVCR is 0.1% of Jacobs Levy Equity Management's reported 13F portfolio.

Current Value

$17.6M

Current Shares

1.2M

Total Value Change

+$15M

Total Shares Change

+1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.2M
-12.6%
$17.6M0.1%$15.15
0
2026-Q1
Increased
1.3M
+8.8%
$14.5M0.1%$10.90
31
2025-Q4
Increased
1.2M
+1093.2%
$15.8M0.1%$12.93
45
2025-Q3
Decreased
102,563
-30.8%
$1.3M0.0%$12.92
0
2025-Q2
New
148,201
-
$2.6M0.0%$17.80
36

Other major holders of NVCR: Capital World Investors, FMR LLC, BAILLIE GIFFORD & CO, Capital International Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used